Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Robust Target Identification for Drug Discovery
KTH, School of Electrical Engineering (EES), Automatic Control. National Cheng Kung Universit, Taiwan.
KTH, School of Electrical Engineering (EES), Automatic Control. National Cheng Kung Universit, Taiwan.
2016 (English)In: IFAC-PapersOnLine, ISSN 2405-8963, Vol. 49, no 7, 815-820 p.Article in journal (Refereed) Published
Abstract [en]

A key step in the development of new pharmaceutical drugs is that of identifying direct targets of the bioactive compounds, and distinguishing these from all other gene products that respond indirectly to the drug targets. Currently dominating approaches to this problem are based on often time consuming and costly experimental methods aimed at locating physical bindings of the corresponding small molecule to proteins or DNA sequences. In this paper we consider target identification based on time-series expression data of the corresponding gene regulatory network, using perturbation with the active compound only. As we show, the problem of identifying the direct targets can then be cast as a linear regression problem and, in principle, be accomplished with a number of samples equal to the number of involved genes and bioactive compounds. However, the regression matrix will typically be highly ill-conditioned and the target identification therefore prone even to small measurement uncertainties. In order to provide a label of confidence for the target identification, we consider conditions that can be used to quantify the robustness of the identification of individual drug targets with respect to uncertainty in the expression data. For this purpose, we cast the uncertain regression problem as a robust rank problem and employ SVD or the structured singular value to compute the robust rank. The proposed method is illustrated by application to a small scale gene regulatory network synthesised in yeast to serve as a benchmark problem in network inference.

Place, publisher, year, edition, pages
Elsevier, 2016. Vol. 49, no 7, 815-820 p.
Keyword [en]
drug discovery, gene regulatory networks, network inference, robust regression, Systems biology, systems medicine, target identification, Benchmarking, DNA sequences, Drug products, Genes, Regression analysis, Uncertainty analysis, Robust regressions, Gene expression
National Category
Control Engineering
Identifiers
URN: urn:nbn:se:kth:diva-195467DOI: 10.1016/j.ifacol.2016.07.290ISI: 000381504800137Scopus ID: 2-s2.0-84991037413OAI: oai:DiVA.org:kth-195467DiVA: diva2:1050215
Note

QC 20161128

Available from: 2016-11-28 Created: 2016-11-03 Last updated: 2016-11-28Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Jacobsen, Elling W.Nordling, Torbjörn E. M.
By organisation
Automatic Control
Control Engineering

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 10 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf